PMA patent complaint v. Korea

Executive Summary

PMA President Mossinghoff is asking the Commerce Department via a March 10 letter "to send an appropriate signal to Korea" for what the association called deviations from a bilateral U.S.-South Korean agreement. "For the past year," the association maintained, "the Korean government has sought to renegotiate the agreement it signed in order to inhibit the sale of U.S. patented products in that country." PMA charged that Korea is not protecting drug product or process patents and is not enforcing its pre-agreement patent laws.